Compare Mutual Funds

Pros
Beats FD returns for both 3Y & 5Y duration.

Beats FD returns for both 3Y & 5Y duration.

Larger AUM within category.

Larger AUM within category.

Beats FD returns for both 3Y & 5Y duration.

Beats FD returns for both 3Y & 5Y duration.

Cons
5Y returns in the bottom 25% of the category.

5Y returns in the bottom 25% of the category.

5Y returns in the bottom 25% of the category.

5Y returns in the bottom 25% of the category.

3Y returns in the bottom 25% of the category.

3Y returns in the bottom 25% of the category.

INDMoney rank
8/8
6/8
Category

Equity, Sector - Healthcare

Equity, Sector - Healthcare

Fund Age

6 Years 7 Months

13 Years 3 Months

Fund AUM

₹837 Cr

₹8265 Cr

Min Investment
  1. SIP ₹100
  2. Lumpsum ₹1000
  1. SIP ₹100
  2. Lumpsum ₹5000
Expense Ratio

1.02%

0.92%

Exit Load

1%

1%

Benchmark Index

BSE Healthcare TR INR

BSE Healthcare TR INR

No of Holdings

38

39

Top 5 Holdings
  1. Sun Pharmaceuticals Industries Ltd(13.47%)
  2. Apollo Hospitals Enterprise Ltd(7.14%)
  3. Cipla Ltd(6.08%)
  4. Torrent Pharmaceuticals Ltd(4.71%)
  5. J.B. Chemicals & Pharmaceuticals Ltd(4.51%)
  1. Sun Pharmaceuticals Industries Ltd(13.02%)
  2. Lupin Ltd(7.36%)
  3. Divi's Laboratories Ltd(6.58%)
  4. Cipla Ltd(6.39%)
  5. Dr Reddy's Laboratories Ltd(6.02%)
No of Sectors

2

1

Top 3 Sectors
  1. Health(99.09%)
  2. Basic Materials(0.91%)

Health

(100%)

Equity %

98.81%

97.37%

Debt %

-

-

P/E

37.68

35.17

P/B

5.46

5.57

Credit Quality

-

-

Modified Duration

-

-

YTM

-

-

1-Month Return

-4.09%

-4.77%

3-Month Return

-6.34%

-6.4%

6-Month Return

-8.07%

-9.62%

1-Year Return

1.35%

2.51%

3-Year Return

21.96%

21.29%

5-Year Return

14.81%

15.66%

Sharpe

0.99

1.02

Alpha

-0.67

-0.2

Beta

0.96

0.91

Standard Deviation

15.86

15.11

Information Ratio

-0.44

-0.5

Description

Aditya Birla Sun Life Pharma & Healthcare Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Managers

Dhaval Shah

Sailesh Raj Bhan, Divya Sharma, Lokesh Maru, Kinjal Desai

Most Popular Comparisons